Modulation of cardioprotective effect of ischemic pre- and postconditioning in the hyperhomocysteinemic rat heart

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 31, Issue 2, 2009, Pages 71-79

  Balakumar, Pitchai ^a   Rohilla, Ankur ^a   Singh, Gurfateh ^a   Singh, Kulwinder ^a   Singh, Manjeet ^a  

^a ISF COLLEGE OF PHARMACY   (India)

Author keywords

Hyperhomocysteinemia; Ischemia reperfusion injury; Oxidative stress; Postconditioning; Preconditioning

Indexed keywords

CREATINE KINASE; GLUTATHIONE; LACTATE DEHYDROGENASE; LIPID; METHIONINE; SUPEROXIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIPHENYLTETRAZOLIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HYPERHOMOCYSTEINEMIA; ISCHEMIC POSTCONDITIONING; ISCHEMIC PRECONDITIONING; ISOLATED HEART; LIPID PEROXIDATION; NONHUMAN; OXIDATIVE STRESS; RAT; REPERFUSION INJURY; ANIMAL; FEMALE; MALE; METABOLISM; METHODOLOGY; PATHOPHYSIOLOGY; SECRETION; WISTAR RAT;

ANIMALS; CREATINE KINASE; FEMALE; GLUTATHIONE; HYPERHOMOCYSTEINEMIA; ISCHEMIC PRECONDITIONING, MYOCARDIAL; L-LACTATE DEHYDROGENASE; LIPID PEROXIDATION; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; OXIDATIVE STRESS; RATS; RATS, WISTAR; SUPEROXIDES;

EID: 68349087094     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.2009.31.2.1357292     Document Type: Article

References (48)

1. Murry, C.E., Jennings, R.B., Reimer, K.A. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 1986, 74(5): 1124-1136
2. Zhao, Z.Q., Corvera, J.S., Halkos, M.E. et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: Comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 2003, 285(2): H579-88.
3. Balakumar, P., Rohilla, A., Singh, M. Preconditioning and postconditioning to limit ischemia-reperfusion-induced myocardial injury: What could be the next footstep? Pharmacol Res 2008, 57(6): 403-412
4. Yellon, D.M., Housenloy, D.J. Myocardial reperfusion injury. N Engl J Med 2007, 357(11): 1121-1135
5. Tsang, A., Hausenloy, D.J., Mocanu, M.M., Yellon, D.M. Postconditioning: A form of "modified reperfusion" protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway. Circ Res 2004, 95(3): 230-232
6. Yang, X.M., Proctor, J.B., Cui, L., Krieg, T., Downey, J.M., Cohen, M.V. Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways. J Am Coll Cardiol 2004, 44(5): 1103-1110
7. Ferdinandy, P., Szilvassy, Z., Baxter, G.F. Adaptation to myocardial stress in disease states: Is preconditioning a healthy heart phenomenon? Trends Pharmacol Sci 1998, 19(6): 223-229
8. Ferdinandy, P., Schulz, R., Baxter, G.F. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. Pharmacol Rev 2007, 59(4): 418-458
9. Katakam, P.V.G., Jordan, J.E., Snipes, J.A., Tulbert, C.D., Miller, A.W., Busija, D.W. Myocardial preconditioning against ischemia-reperfusion injury is abolished in Zucker obese rats with insulin resistance. Am J Physiol Regul Integr Comp Physiol 2007, 292(2): R920-6.
10. Ebrahim, Z., Yellon, D.M., Baxter, G.F. Ischemic preconditioning is lost in aging hypertensive rat heart: Independent effects of aging and longstanding hypertension. Exp Gerontol 2007, 42(8): 807-814
11. Vessani, R.A., Ritch, R., Liebmann, J.M., Jofe, M. Plasma homocysteine is elevated in patients with exfoliation syndrome. Amer J Ophthalmol 2003, 136(1): 41-46
12. Balakumar, P., Singh, A.P., Ganti, G.S., Singh, M. Hyperhomocysteinemia and cardiovascular disorders: Is there a correlation? Trends Med Res 2007, 2: 160-166
13. Loscalzo, J. Homocysteine trials - Clear outcomes for complex reasons. N Engl J Med 2006, 354(15): 1629-1632
14. Tyagi, N., Sedoris, K.C., Steed, M., Ovechkin, A.V., Moshal, K.S., Tyagi, S.C. Mechanisms of homocysteine-induced oxidative stress. Am J Physiol Heart Circ Physiol 2005, 289(6): H2649-56.
15. Austin, R., Lentz, S., Werstuck, G. Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease. Cell Death Differ 2004, 11(Suppl. 1): S56-64.
16. Nygård, O., Vollset, S.E., Refsum, H. et al. Total homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA 1995, 274(19): 1526-1533
17. Helfenstein, T., Fonseca, F.A.H., Relvas, W.G.M. et al. Prevalence of myocardial infarction is related to hyperhomocysteinemia but not influenced by C677T methylenetetrahydrofolate reductase and A2756G methionine synthase polymorphisms in diabetic and non-diabetic subjects. Clin Chim Acta 2005, 355(1-2): 165-172
18. Herrmann, M., Kindermann, I., Muller, S. et al. Relationship of plasma homocysteine with the severity of chronic heart failure. Clin Chem 2005, 51(8): 1512-1515
19. Barabasi, A.L. Network medicine - From obesity to the "diseasome". N Engl J Med 2007, 357(4): 404-407
20. Suematsu, N., Ojaimi, C., Kinugawa, S. et al. Hyperhomocysteinemia alters cardiac substrate metabolism by impairing nitric oxide bioavailability through oxidative stress. Circulation 2007, 115(2): 255-262
21. 1/2/p38MAPK activation. Biochem Biophys Res Commun 2007, 360(1): 20-26
22. Becker, J.S., Adler, A., Schneeberger, A. et al. Hyperhomocysteinemia, a cardiac metabolic disease. Circulation 2005, 111(16): 2112-2118
23. Riksen, N.P., Rongen, G.A., Boers, G.H., Blom, H.J., van den Broek, P.H., Smits, P. Enhanced cellular adenosine uptake limits adenosine receptor stimulation in patients with hyperhomocysteinemia. Arterioscler Thromb Vasc Biol 2005, 25(1): 109-114
24. Langendorff, O. Untersuchungen am uberlebenden Saugethierherzen. Archiv fur die gesammte Physiologie des Menschen und der Thiere Bonn 1895, 61: 291-332.
25. Lie, J.T., Pairdero, P.C., Holley, K.E., Tilus, J.L. Macroscopic enzyme mapping verification of large, homogenous, experimental myocardial infarcts of predictable size and location in dogs. J Thorac Cardiovasc Surg 1975, 69(4): 599-606.
26. Fishbein, M.C., Meerbaum, S., Rit, J., Lando, U., Coroday, E., Ganz, W. Early phase acute myocardial infarct size quantification: Validation of the triphenyltetrazolium chloride tissue enzyme staining technique. Am Heart J 1981, 101(5): 563-600.
27. Chopra, K., Singh, M., Kaul, N., Ganguly, N.K. Decrease of myocardial infarct size with desferroxamine: Possible role of oxygen free radicals in its ameliorative effect. Mol Cell Biochem 1992, 113(1): 71-76
28. Parikh, V., Singh, M. Possible role of adrenergic component and cardiac mast cell degranulation in preconditioning-induced cardioprotection. Pharmacol Res 1999, 40(2): 129-137
29. Ohkawa, H., Ohishi, N., Yagi, K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979, 95(2): 351-358
30. Singh, A.P., Singh, M., Balakumar, P. Ameliorative effect of mast cell stabilizers in hyperhomocysteinemia-induced cardiac hypertrophy in rats. J Cardiovasc Pharmacol 2008, 51(6): 596-604.
31. Wang, H.D., Pagano, P.J., Du, Y. et al. Superoxide anion from the adventitia of the rat thoracic aorta inactivates nitric oxide. Circ Res 1998, 82(7): 810-818
32. Beutler, E., Duron, O., Kefly, B.M. Improved method for the determination of blood glutathione. J Lab Clin Med 1963, 61: 882-888
33. Collard, C.D., Gelman, S. Pathophysiology, clinical manifestations, and prevention of ischemia-reperfusion injury. Anesthesiology 2001, 94(6): 1133-1138
34. Di Napoli, P.D., Taccardi, A.A., De Caterina, R., Barsotti, A. Pathophysiology of ischemia-reperfusion injury: Experimental data. Ital Heart J 2002, 3(Suppl. 4): 24S-28S.
35. Aktan, A.O., Yalcin, A.S. Ischemia-reperfusion injury, reactive oxygen metabolites and the surgeon. Turk J Med Sci 1998, 28: 1-5.
36. Jordan, J.E., Zhao, Z.Q., Vinten-Johansen, J. The role of neutrophils in myocardial ischemia-reperfusion injury. Cardiovasc Res 1999, 43(4): 860-878
37. + exchange inhibitor on cardioprotective effect of ischaemic preconditioning: Possible involvement of resident cardiac mast cells. Pharmacol Res 1997, 36(2): 95-102.
38. Sharma, A., Singh, M. Possible mechanism of cardioprotective effect of ischaemic preconditioning in isolated rat heart. Pharmacol Res 2000, 41(6): 635-640.
39. Sharma, A., Singh, M. Possible mechanism of cardioprotective effect of angiotensin preconditioning in isolated rat heart. Eur J Pharmacol 2000, 406(1): 85-92.
40. Ungvari, Z., Csiszar, A., Edwards, J.G. et al. Increased superoxide production in coronary arteries in hyperhomocysteinemia: Role of tumor necrosis factor- α, NAD(P)H oxidase, and inducible nitric oxide synthase. Arterioscler Thromb Vasc Biol 2003, 23(3): 418-424
41. Devi, S., Kennedy, R.H., Joseph, L., Shekhawat, N.S., Melchert, R.B., Joseph, J. Effect of long-term hyperhomocysteinemia on myocardial structure and function in hypertensive rats. Cardiovasc Pathol 2006, 15(2): 75-82.
42. Ozer, M., Parlakpinar, H., Cigremis, Y., Ucar, M., Vardi, N., Acet, A. Ischemia-reperfusion leads to depletion of glutathione content and augmentation of malondialdehyde production in the rat heart from overproduction of oxidants: Can caffeic acid phenethyl ester (CAPE) protect the heart? Mol Cell Biochem 2005, 273(1-2): 169-175
43. Shah, D.I., Singh, M. Possible role of Akt to improve vascular endothelial dysfunction in diabetic and hyperhomocysteinemic rats. Mol Cell Biochem 2007, 295(1-2): 65-74.
44. Bertuglia, S., Giusti, A., Del Soldato, P. Antioxidant activity of a nitro derivative of aspirin against ischemia-reperfusion in hamster cheek pouch microcirculation. Am J Physiol Gastrointest Liver Physiol 2004, 286(3): G437-43.
45. Rastaldo, R., Penna, C., Cappello, S., Mancardi, D., Pagliaro, P., Losano, G. Ischemic postconditioning: An effective strategy of myocardial protection? G Ital Cardiol (Rome) 2006, 7(7): 464-473
46. Javadov, S.A., Clarke, S., Das, M., Griffiths, E.J., Lim, K.H.H., Halestrap, A.P. Ischaemic preconditioning inhibits opening of mitochondrial permeability transition pores in the reperfused rat heart. J Physiol 2003, 549(Pt. 2): 513-524
47. Argaud, L., Gateau-Roesch, O., Raisky, O., Loufouat, J., Robert, D., Ovize, M. Postconditioning inhibits mitochondrial permeability transition. Circulation 2005, 111(2): 194-197
48. Lim, S.Y., Davidson, S.M., Hausenloy, D.J., Yellon, D.M. Preconditioning and postconditioning: The essential role of the mitochondrial permeability transition pore. Cardiovasc Res 2007, 75(3): 530-535